NYSEARCA:MSGR Direxion mRNA ETF - MSGR Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Direxion mRNA ETF Please log in to your account or sign up in order to add this asset to your watchlist. $15.84 -0.09 (-0.56%) (As of 02/3/2023 09:04 PM ET) Add Share Share Today's Range$15.62▼$16.3750-Day Range$13.47▼$16.1652-Week Range$11.55▼$19.55Volume3,000 shsAverage Volume5,574 shsMarket Capitalization$4.44 millionP/E RatioN/ADividend Yield0.00%Price TargetN/A ProfileChartInstitutional OwnershipHeadlines Receive MSGR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion mRNA ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive MSGR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion mRNA ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Basic Details Issuer Direxion Fund NameDirexion mRNA ETF Tax ClassificationRegulated Investment Company SymbolNYSEARCA:MSGR Inception Date12/9/2021 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkBITA Messenger RNA Technology Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Fund Statistics Assets Under Management$4.01 million Average Daily Volume$0.00 Discount/Premium0.00% ETF Expenses Management Fee0.60% Other Expenses0.05% Total Expenses0.65% Fee Waiver0.00% Net Expenses0.65%Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation Trustee Lead Market MakerSusquehanna Geographic Exposure of MSGRCurrency Exposure of MSGRSector Exposure of MSGRIndustry Exposure of MSGR Insiders & InstitutionsUBS Group AGBought 753 shares on 11/10/2022Ownership: 10.724%View All Institutional Transactions MSGR Stock - Frequently Asked Questions How have MSGR shares performed in 2023? Direxion mRNA ETF's stock was trading at $14.2377 at the beginning of the year. Since then, MSGR shares have increased by 11.3% and is now trading at $15.84. View the best growth stocks for 2023 here. What is Direxion mRNA ETF's stock symbol? Direxion mRNA ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "MSGR." How do I buy shares of Direxion mRNA ETF? Shares of MSGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Direxion mRNA ETF's stock price today? One share of MSGR stock can currently be purchased for approximately $15.84. How much money does Direxion mRNA ETF make? Direxion mRNA ETF (NYSEARCA:MSGR) has a market capitalization of $4.44 million. This page (NYSEARCA:MSGR) was last updated on 2/6/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.